FDA Inspection 1170764 — Versiti Blood Health Inc

Versiti Blood Health Inc — FEI 3004888204

The FDA completed an inspection of Versiti Blood Health Inc on May 25, 2022 in Yorkville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 25, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Yorkville, IL (United States)